- Home
- CLYM vs FTK Comparison
CLYM vs FTK Comparison
Compare CLYM & FTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLYM
- FTK
- Stock Information
- Founded
- CLYM 2018
- FTK 1985
- Country
- CLYM United States
- FTK United States
- Employees
- CLYM N/A
- FTK N/A
- Industry
- CLYM
- FTK Major Chemicals
- Sector
- CLYM
- FTK Industrials
- Exchange
- CLYM NYSE
- FTK Nasdaq
- Market Cap
- CLYM 201.7M
- FTK 219.3M
- IPO Year
- CLYM 2021
- FTK N/A
- Fundamental
- Price
- CLYM $1.95
- FTK $7.27
- Analyst Decision
- CLYM
- FTK Strong Buy
- Analyst Count
- CLYM 0
- FTK 2
- Target Price
- CLYM N/A
- FTK $7.50
- AVG Volume (30 Days)
- CLYM 264.1K
- FTK 178.4K
- Earning Date
- CLYM 11-12-2024
- FTK 11-04-2024
- Dividend Yield
- CLYM N/A
- FTK N/A
- EPS Growth
- CLYM N/A
- FTK N/A
- EPS
- CLYM N/A
- FTK 0.27
- Revenue
- CLYM N/A
- FTK $178,455,000.00
- Revenue This Year
- CLYM N/A
- FTK N/A
- Revenue Next Year
- CLYM N/A
- FTK $13.93
- P/E Ratio
- CLYM N/A
- FTK $26.97
- Revenue Growth
- CLYM N/A
- FTK N/A
- 52 Week Low
- CLYM $1.86
- FTK $2.64
- 52 Week High
- CLYM $11.55
- FTK $9.14
- Technical
- Relative Strength Index (RSI)
- CLYM N/A
- FTK 41.36
- Support Level
- CLYM N/A
- FTK $7.71
- Resistance Level
- CLYM N/A
- FTK $8.24
- Average True Range (ATR)
- CLYM 0.00
- FTK 0.36
- MACD
- CLYM 0.00
- FTK -0.23
- Stochastic Oscillator
- CLYM 0.00
- FTK 7.70
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven company focused on reducing the environmental impact of energy operations. Its Chemistry Technologies segment develops green specialty chemicals to enhance the profitability of hydrocarbon producers, catering to major players in the oil and gas industry. These chemicals improve operational efficiency and sustainability throughout the well life cycle. The Data Analytics segment provides real-time analytics for hydrocarbon streams, enabling users to optimize processes and increase profitability by reducing waste and reprocessing. Flotek's revenue primarily comes from its Chemistry segment, reflecting its commitment to providing solutions for environmental improvement in the energy sector.